Chao Zhao

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Sha Zhao, Shengxiang Ren, Tao Jiang et al. · Cancer Immunology Research · 2019 · 334 citations

Medicine, Oncology, Pharmacology +17

Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer

Sha Zhao, Guanghui Gao, Wei Li et al. · Lung Cancer · 2019 · 164 citations

Medicine, Oncology, Pharmacology +14

EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapies

Yijun Jia, Xuefei Li, Tao Jiang et al. · International Journal of Cancer · 2019 · 162 citations · Full text

Medicine, Immunology, Oncology +17

Long non-coding RNA <i>UCA1</i> induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in <i>EGFR</i>-mutant non-small cell lung cancer

Ningning Cheng, Weijing Cai, Shengxiang Ren et al. · Oncotarget · 2015 · 149 citations · Full text

Medicine, Molecular Biology, Oncology +17

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases

Tao Jiang, Chunxia Su, Xuefei Li et al. · Journal of Thoracic Oncology · 2016 · 149 citations · Full text

Medicine, Oncology, Immunotherapy +10